. Author manuscript; available in PMC: 2015 Jul 29.

Published in final edited form as: Appl Immunohistochem Mol Morphol. 2014 Jul;22(6):442–448. doi: 10.1097/PAI.0b013e318294ca46

TABLE 1.

Mammaglobin-A immunohistochemical staining distribution and intensities. Cases considered ‘positive’ by established intensity and proportionality scoring have been shaded gray.

Tumor	Distribution	Intensity
Tumor	Distribution	0 (none)	1+ (weak)	2+ (moderate)	3+ (strong)
Glioblastoma (n=12)	<5%	-	3/12 (25.0%)	0/12 (0.0%)	0/12 (0.0%)
	5–90%	-	2/12 (16.7%)	3/12 (25.0%)	0/12 (0.0%)
	>90%	4/12 (33.3%)	0/12 (0.0%)	0/12 (0.0%)	0/12 (0.0%)

Meningioma (n=10)	<5%	-	4/10 (40.0%)	0/10 (0.0%)	0/10 (0.0%)
	5–90%	-	2/10 (20.0%)	1/10 (10.0%)	0/10 (0.0%)
	>90%	3/10 (30.0%)	0/10 (0.0%)	0/10 (0.0%)	0/10 (0.0%)

Metastatic Carcinoma, Brain (n=95)	<5%	-	10/95 (10.5%)	11/95 (11.6%)	7/95 (7.4%)
	5–90%	-	17/95 (17.9%)	22/95 (23.2%)	17/95 (17.9%)
	>90%	2/95 (2.1%)	0/95 (0.0%)	8/95 (8.4%)	1/95 (1.0%)

Primary Carcinoma, Breast (n=32)	<5%	-	3/32 (9.4%)	5/32 (15.6%)	3/32 (9.4%)
	5–90%	-	4/32 (12.5%)	5/32 (15.6%)	8/32 (25.0%)
	>90%	2/32 (6.3%)	0/32 (0.0%)	2/32 (6.3%)	0/32 (0.0%)